[Antibacterial drugs in the treatment of bronchopulmonary suppurations (apropos of the trial of a new bactericide)].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000188:drug therapy*; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000150:complications
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D010406:Penicillins; D011743:Pyrimidines; D013420:Sulfamethoxazole
Les médications anti-bactériennes dans le traitement des suppurations broncho-pulmonaires (à propos de l'essai d'un nouveau bactéricide.